Apricitabine (Synonyms: AVX754, BCH 10618, (–)-BCH 10652, (–)-dOTC, SPD-754) |
Katalog-Nr.GC49776 |
Apricitabin (SPD754; AVX754), das (-)-Enantiomer von 2′-Desoxy-3′-oxa-4′-thiocytidin (dOTC), ist ein hochselektiver und oral aktiver HIV-1-Reverse-Transkriptase (RT)-Hemmer (Ki= 0,08 μM) und hemmt die DNA-Polymerasen α, β und γ mit einem Ki-Wert von 300 μM, 12 μM bzw. 112,25 μM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 160707-69-7
Sample solution is provided at 25 µL, 10mM.
Apricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) and derivative of 2’-deoxycytidine .1 It is phosphorylated intracellularly to its active form, apricitabine-5’-triphosphate, which competes with a monophosphate form for binding to HIV-1 reverse transcriptase and incorporation into the nascent viral DNA, inducing chain termination and HIV-1 replication. Apricitabine reduces HIV-1 infectivity in MT-4 and U937 cells (IC50s = 2.8 and 0.4 µM, respectively), as well as in isolated human cord blood mononuclear cells (CBMCs; IC50 = 0.4 µM).2
1.Cox, S., and Southby, J.Apricitabine--a novel nucleoside reverse transcriptase inhibitor for the treatment of HIV infection that is refractory to existing drugsExpert Opin. Investig. Drugs18(2)199-209(2009) 2.Mansour, T.S., Jin, H., Wang, W., et al.Structure-activity relationships among a new class of antiviral heterosubstituted 2′,3′-dideoxynucleoside analoguesNucleos. Nucleot.14(3-5)627-635(1995)
Average Rating: 5
(Based on Reviews and 7 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *